FDA Guidance on Electronic Signatures in Clinical Trials – What Stakeholders Need to Know
Highlights The Food and Drug Administration (FDA) guidance on electronic systems, electronic records, and electronic signatures in clinical trials is a crucial update for sponsors, clinical investigators, institutional review boards (IRBs), contract research organizations (CROs), and…